Home › Executives › Brantley Carlson
BC

Brantley Carlson

Executive Director at AstraZeneca

AstraZeneca•Washington DC-Baltimore Area, United States

View LinkedIn Profile
Experience23+ Years
LevelCXO

Career Timeline

Professional employment history
  • AstraZenecaCurrent
    May 2014–Present· 12 yrs 5 mos
    • Executive DirectorCurrent
      2026–Present
    • Senior Director, Oncology Market Access Strategy, Policy
      Oct 2019–2026
    • Director, Corporate Affairs, Oncology
      2018–Dec 2019
    • Director, Federal Government Affairs & Policy
      May 2014–2018
  • UnitedHealth Group
    Aug 2011–May 2014· 2 yrs 9 mos
    • Director, Information Technology
      Aug 2011–May 2014
  • Avalere
    Jun 2007–Aug 2011· 4 yrs 2 mos
    • Manager, Information Technology
      Jun 2007–Aug 2011
  • Blue Cross Blue Shield of Michigan
    May 2006–Sep 2006· 4 mos
    • Clinical Program Development Intern
      May 2006–Sep 2006
  • University of Michigan
    Jul 2005–Dec 2006· 1 yr 5 mos
    • Instructor, Chemistry
      Jul 2005–Dec 2006
  • University of Michigan Medical School
    Aug 2003–Apr 2007· 3 yrs 8 mos
    • Surgical and Chemistry Researcher, Meyerhoff Lab and Advanced Life Support/ECMO Research Laboratory
      Aug 2003–Apr 2007

Education

Bachelor of Science

Biochemistry

University of Michigan

Executive Relationship Map

Reports To
Brantley Carlson
Vice Chair & President
Chief Financial Officer
Chief Technology Officer
Chief Operating Officer

Executive Network Preview

BizKonnect has mapped this leadership network including reporting hierarchies, peer connections, and cross-functional relationships.

Verified Contact Information
Email & Direct Dial
Org Chart & Reporting Lines
Buying Committee Insights
AI-Powered Account Mapping

Skills & Expertise

20 of 20 skills
HospitalsHealthcare ManagementPolicy AnalysisHealth EconomicsPublic PolicyOrthopedicMedicaidManaged CareHealth PolicyHealthcare Information TechnologyHealthcareData AnalysisHealth InsuranceMedical DevicesMedicareHealthcare ConsultingPharmaceutical IndustryBiotechnologyPublic HealthMarket Access